A Phase Ib pharmacokinetic study of the anti-angiogenic agent CKD-732 used in combination with capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer patients who progressed on irinotecan-based chemotherapy
暂无分享,去创建一个
Tae Won Kim | J. Roh | H. Chung | S. Rha | S. Shin | Y. J. Lee | Y. Hong | J. Ahn | Dal-hyun Kim | H. Kim | Kyung Soo Park | Chin Kim | Chin Kim | Hyun Cheol Chung | K. Park | H. Chung | Y. Hong | S. Shin | Hye Ryun Kim